Clarity Pharmaceuticals Ltd

CHIA:CU6 Stock Report

Market Cap: AU$2.7b

Clarity Pharmaceuticals Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

CHIA:CU6 Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
23 Sep 24BuyAU$3,755,075Bank of America Corporation, Asset Management ArmCompany444,419AU$8.45
23 Sep 24SellAU$2,097,510Bank of America Corporation, Asset Management ArmCompany250,293AU$8.38
20 Sep 24BuyAU$47,678Merrill Lynch & Co. Inc., Banking InvestmentsCompany5,479AU$8.70
20 Sep 24SellAU$1,539,908Merrill Lynch & Co. Inc., Banking InvestmentsCompany185,399AU$8.31
17 Sep 24BuyAU$55,557,322Bank of America Corporation, Asset Management ArmCompany10,426,657AU$5.33
17 Sep 24SellAU$42,321,738Bank of America Corporation, Asset Management ArmCompany7,362,426AU$5.75
12 Sep 24BuyAU$2,522,932Merrill Lynch & Co. Inc., Banking InvestmentsCompany409,239AU$6.16
03 Sep 24SellAU$1,595,408Merrill Lynch & Co. Inc., Banking InvestmentsCompany221,711AU$7.20
20 May 24BuyAU$67,997Robert ThomasIndividual15,908AU$4.40
29 Apr 24BuyAU$86,935Robert ThomasIndividual34,092AU$2.55
29 Nov 23SellAU$387,963Charles MorganIndividual300,000AU$1.29

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of CU6?
Owner TypeNumber of SharesOwnership Percentage
State or Government3,599,9201.14%
Institutions25,002,2647.91%
Private Companies40,922,03012.9%
Individual Insiders56,818,94618%
General Public189,737,89660%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 20.7%.


Top Shareholders

Top 25 shareholders own 39.89% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
5.94%
TM Ventures Pty Ltd.
18,788,460AU$162.5m200%no data
5.67%
Christopher Roberts
17,911,280AU$154.9m0%no data
4.62%
Alan Taylor
14,609,662AU$126.4m3.86%no data
2.93%
Argo Investments Limited
9,247,447AU$80.0m0%1.08%
2.47%
Yarrawah Pty Ltd
7,803,450AU$67.5m0%no data
2.37%
Vantres Pty Ltd
7,487,340AU$64.8m0%no data
2.09%
Charles Morgan
6,600,041AU$57.1m0%no data
1.92%
Matthew Harris
6,065,800AU$52.5m0%no data
1.58%
Smarter Capital Pty Ltd
5,004,543AU$43.3m0%no data
1.48%
Bank of America Corporation, Asset Management Arm
4,675,014AU$40.4m0%0.01%
1.42%
The Vanguard Group, Inc.
4,493,037AU$38.9m0%no data
1.23%
Kylaco Pty Ltd
3,896,280AU$33.7m0%no data
1.14%
Australian Nuclear Science and Technology Organisation
3,599,920AU$31.1m0%no data
1.03%
Colin Biggin
3,249,764AU$28.1m80.4%no data
0.99%
Guido Belgiorno-Nettis
3,116,000AU$27.0m0%no data
0.93%
UM Commercialisation Pty Ltd
2,946,500AU$25.5m0%no data
0.88%
Malvin Eutick
2,768,320AU$23.9m0%no data
0.36%
Robert Thomas
1,145,000AU$9.9m0%no data
0.17%
Merrill Lynch & Co. Inc., Banking Investments
548,412AU$4.7m0%no data
0.17%
Michelle Parker
535,000AU$4.6m0%no data
0.16%
Thomas Ramdahl
520,000AU$4.5m0%no data
0.13%
Portland Investment Counsel Inc.
400,235AU$3.5m0%0.71%
0.12%
Norges Bank Investment Management
367,730AU$3.2m0%no data
0.056%
Rosanne Robinson
178,079AU$1.5m0%no data
0.038%
Charles O'Bryan-Tear
120,000AU$1.0m0%no data